Jul 9, 2026 04:05PM
Jun 29, 2026 03:00AM
Jun 29, 2026 03:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM
Jun 5, 2026 08:00AM Amneal Announces Full Study Population Interim Phase 4 ELEVATE-PD Results, Reinforcing Previously Reported Benefits of CREXONT® in Parkinson's Disease
Jun 4, 2026 08:00AM
Jun 4, 2026 08:00AM
May 7, 2026 04:01PM
Apr 22, 2026 06:00AM
Apr 22, 2026 06:00AM
Apr 20, 2026 08:02AM
Apr 20, 2026 08:00AM Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
Apr 14, 2026 08:00AM
Apr 9, 2026 08:00AM
Apr 7, 2026 04:01PM
Apr 7, 2026 08:00AM
Apr 7, 2026 08:00AM
Feb 27, 2026 06:35AM
Feb 27, 2026 06:00AM Amneal Reports Fourth Quarter and Full Year 2025 Financial Results
Jan 27, 2026 08:00AM
Dec 22, 2025 04:01PM
Dec 22, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 9, 2025 04:01PM
Dec 5, 2025 08:02AM
Dec 5, 2025 08:00AM Amneal Announces Positive Interim Phase 4 ELEVATE-PD Results With CREXONT® for Parkinson’s Disease
Dec 2, 2025 08:00AM
Dec 2, 2025 08:00AM
Dec 1, 2025 04:01PM
Dec 1, 2025 04:01PM
Nov 13, 2025 04:01PM
Nov 13, 2025 04:01PM
Oct 30, 2025 06:04AM Amneal Pharmaceuticals (AMRX) Tops Q3 EPS by 3c, provides guidance
Oct 30, 2025 06:00AM
Oct 29, 2025 04:09PM
Oct 29, 2025 04:05PM
Oct 27, 2025 08:00AM
Sep 30, 2025 04:05PM
Sep 26, 2025 08:02AM
Sep 26, 2025 08:00AM Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)
Sep 23, 2025 08:00AM
Sep 23, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 11, 2025 08:00AM
Sep 4, 2025 04:01PM
Sep 4, 2025 04:01PM
Aug 5, 2025 06:10AM Amneal Pharmaceuticals (AMRX) Tops Q2 EPS by 8c, raises guidance
Aug 5, 2025 06:00AM

1,204,710 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All